As of 2023, the share of scientific publications involving international collaboration in Endocrinology, Diabetes, and Metabolism in the US stood at 24.35%. The forecasted values from 2024 to 2028 show a consistent year-on-year increase, with a projected rise to 26.4% by 2028, indicating growing international collaboration. From 2024 onwards, the average annual growth rate is estimated to be 1.26%, demonstrating a steady upward trend in global collaborative efforts.

Future trends to watch for include:

Increased emphasis on international collaboration driven by global health challenges in diabetes and metabolism.
Advancements in digital tools facilitating cross-border research partnerships.
Potential policy changes impacting international research funding and collaborations.